Related Experiment Video
Updated: May 29, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
MicroRNA-7: a versatile player and core target in brain disorders
Jianhua Deng1, Daosheng Li1, Zhiqi Li2
1Department of Oncology, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang No.1 People's Hospital, No.48 Taling South Road, Xunyang District, Jiujiang, Jiangxi Province, 332001, China.
MicroRNA-7 (miR-7) is a key regulator in brain diseases, impacting neuroinflammation and protein aggregation. Its potential in diagnostics and therapeutics for neurological disorders is significant, though challenges remain for clinical translation.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- MicroRNA-7 (miR-7) is highly expressed in mammalian brain tissues.
- Its function is intricately regulated by competing endogenous RNA (ceRNA) networks and epigenetic modifications.
- This forms a complex, multi-layered regulatory system crucial for neural function.
Purpose of the Study:
- To systematically review the biological characteristics and regulatory mechanisms of miR-7 in the nervous system.
- To explore the roles of miR-7 in various neurological diseases.
- To assess the clinical translation potential and challenges of miR-7.
Main Methods:
- Systematic review of existing basic and clinical research on miR-7.
- Analysis of miR-7's regulatory networks, including ceRNA interactions and epigenetic modifications.
- Evaluation of miR-7's therapeutic targets and roles in disease pathogenesis.
Main Results:
- miR-7 targets key factors involved in protein aggregation, neuroinflammation, mitochondrial dysfunction, and tumor progression.
- It plays significant roles in Parkinson's disease, Alzheimer's disease, stroke, and glioblastoma.
- Altered miR-7 levels in biofluids suggest diagnostic/prognostic potential, with nanomedicine enhancing therapeutic delivery.
Conclusions:
- miR-7 is a critical regulatory molecule in brain diseases with substantial research and clinical value.
- Further research using advanced technologies like single-cell sequencing is needed.
- Addressing challenges in mechanism complexity and delivery systems is crucial for clinical application.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Pharmacogenomics: Identification of New Drug Targets

